Patients with COVID-19: in the dark-NETs of neutrophils
2021 · Cell Death and Differentiation · 313 citations
https://doi.org/10.1038/s41418-021-00805-z
C
Cansu Yanginlar
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
21
Papers
1.2K
Citations
13
h-index
14
i10-index
Cansu Yanginlar is an academic researcher from Radboud University Nijmegen. The author has contributed to research in topics: Immune responses and vaccinations & COVID-19 Clinical Research Studies & Venous Thromboembolism Diagnosis and Management. The author has an h-index of 13, co-authored 18 publications.
ORCID: 0000-0002-0282-1078Papers by this author
worksIncreased Plasma Heparanase Activity in COVID-19 Patients
2020 · Frontiers in Immunology · 132 citations
https://doi.org/10.3389/fimmu.2020.575047
Hydroxychloroquine Inhibits the Trained Innate Immune Response to Interferons
2020 · Cell Reports Medicine · 45 citations
https://doi.org/10.1016/j.xcrm.2020.100146
Selective Binding of Heparin/Heparan Sulfate Oligosaccharides to Factor H and Factor H-Related Proteins: Therapeutic Potential for C3 Glomerulopathies
2021 · Frontiers in Immunology · 18 citations
https://doi.org/10.3389/fimmu.2021.676662
Acid ceramidase regulates innate immune memory
2023 · Cell Reports · 14 citations
https://doi.org/10.1016/j.celrep.2023.113458
Trained immunity is regulated by T cell-induced CD40-TRAF6 signaling
2024 · Cell Reports · 12 citations
https://doi.org/10.1016/j.celrep.2024.114664
Research topics
topicsChat about Author
Papers
Chat
Click to start Chat